Ufp Technologies (UFPT) EPS (Basic) Growth (5y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Ufp Technologies | 1.69 Bn | 1.67 Bn | 44.36 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 32.78% |
| Dec 31, 2025 | 32.42% |
| Sep 30, 2025 | 39.59% |
| Jun 30, 2025 | 48.38% |
| Mar 31, 2025 | 33.92% |
| Dec 31, 2024 | 22.25% |
| Sep 30, 2024 | 22.89% |
| Jun 30, 2024 | 23.34% |
| Mar 31, 2024 | 26.90% |
| Dec 31, 2023 | 20.43% |
| Sep 30, 2023 | 22.26% |
| Jun 30, 2023 | 23.64% |
| Mar 31, 2023 | 39.77% |
| Dec 31, 2022 | 24.13% |
| Sep 30, 2022 | 62.17% |
| Jun 30, 2022 | 26.80% |
| Mar 31, 2022 | 16.36% |
| Dec 31, 2021 | 15.41% |
| Sep 30, 2021 | 6.21% |
| Jun 30, 2021 | 10.64% |
| Mar 31, 2021 | 29.67% |
| Dec 31, 2020 | 18.47% |
| Sep 30, 2020 | 7.39% |
| Jun 30, 2020 | -0.63% |
| Mar 31, 2020 | 17.72% |
| Dec 31, 2019 | 28.81% |
| Sep 30, 2019 | 21.25% |
| Jun 30, 2019 | 18.09% |
| Mar 31, 2019 | 10.95% |
| Dec 31, 2018 | 4.13% |
| Sep 30, 2018 | 5.92% |
| Jun 30, 2018 | 4.18% |
| Mar 31, 2018 | -4.36% |
| Dec 31, 2017 | -4.56% |
| Sep 30, 2017 | -10.02% |
| Jun 30, 2017 | -2.57% |
| Mar 31, 2017 | -3.58% |
| Dec 31, 2016 | -14.51% |
| Sep 30, 2016 | 0.00% |
| Jun 30, 2016 | -1.98% |
| Mar 31, 2016 | -15.10% |
| Dec 31, 2015 | -13.30% |
| Sep 30, 2015 | -5.92% |
| Jun 30, 2015 | -2.86% |